［1］黄展智. 婴幼儿重症肺炎的药物辅助治疗现状［J］. 医学综述，2009，4 (15): 1234-1236.

［2］陈贤楠. 重症患儿肺炎的定义和诊断标准［J］. 实用儿科临床杂志，2006，21(16)：1118-1120.

［3］Asghar R, Banajeh S, Egas J, Hibberd P, lqbal I, Katep-Bwalya, et al. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study)［J］. BMJ, 2008, 336(7635): 80-84.

［4］Hippenstiel S, Witzenrath M, Opitz B, Schütte H, Rosseau S, Suttorp N. New aspects of the pathophysiology of pneumonia［J］. Internist, 2007, 48(5): 459-467.

［5］Nagarkar DR, Wang Q, Shim J, Zhao Y, Tsai W, Lukacs NW, et al. CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection［J］. J Immunol, 2009, 183(10): 6698-6707.

［6］Kieninger AN, Lipsett PA. Hospital-acquired pneumonia: pathophysiology, diagnosis, and treatment［J］. Surg Clin North Am, 2009, 89(2):439-461.

［7］齐建光，张韶杰，陈永红，杜军保. 儿童重症支原体肺炎的临床特征和治疗探讨［J］.中国当代儿科杂志，2008，10(6): 719-722.

［8］陈艺坛，黄圣排，陈志斌. 东茛菪碱佐治重症肺炎并呼吸衰竭的疗效观察［J］. 临床肺科杂志，2006，11(6): 707-708.

［9］郑福禄，刘宇鹏，姚福军. 东莨菪碱对重症肺感染引起的急性呼吸窘迫综合征的疗效影响［J］. 中国老年学杂志，2009，29(18): 2379-2380.